By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aptuit LLC 

Two Greenwich Office Park

Greenwich  Connecticut  06831  U.S.A.
Phone: 203-422-6600 Fax: 203-422-0266


Aptuit provides early to mid-phase drug development solutions by applying scientific excellence, outstanding service and a global assembly some of the foremost scientific professionals in the industry. These drug discovery and development professionals offer proven experience in key therapeutic areas. They share a legacy of success, having advanced a large number of molecules efficiently, expeditiously and economically, from early discovery through clinical development with low attrition rates.

Aptuit’s provides comprehensive drug development services that are available as a fully integrated offering or on a standalone basis.

These services include:
•   Drug Design & Discovery
•   Preclinical Biosciences
•   API Development & Manufacture
•   Solid State Chemistry
•   Pharmaceutical Services
•   Sterile Fill Finish & Formulation Development
•   Inhaled and Oral Dosage Form Development & Manufacture
•   Physical & Analytical Chemistry
•   Aptuit INDiGO® - fast track to IND program
•   Integrated Drug Discovery & Development

Aptuit is comprised of a global family of world class facilities that serve more than 600 clients. The client base spans small companies that may not maintain in-house technical expertise to multinational entities that turn to Aptuit for large, integrated products.

Fully integrated drug discovery & development services are available from a single site at The Aptuit Center for Drug Discovery & Development in Verona, Italy. This facility combines the proven efficiency of a CRO with the well established scientific expertise of an accomplished and successful Research and Development engine. The breadth of Aptuit Verona’s capabilities bring added value to customers who benefit from the resources of a single site compared to dealing with several suppliers.

Aptuit offers specialized, outstanding services from other facilities in the United States and Europe. Aptuit SSCI in West Lafayette, Indiana is recognized around the world for its solid state chemistry leadership and its outsourcing services. Chief among these are analytical services that employ advanced technology and instrumentation.

Aptuit’s Glasgow, Scotland site has built a notable reputation for the high quality of its sterile fill finish and formulation development for a vast range of dosage forms. Their capabilities include the development of liquid and lyophilized dosage forms, complemented by GMP sterile manufacturing facilities including lyophilized and cytotoxic products.

Aptuit’s dedicated API development and manufacturing facility in Oxford, England has industry-leading competencies in process R&D, analytical and chemical development, preclinical and clinical supply, high potency APIs and cytotoxics, pilot manufacturing and commercial scale manufacturing.

Aptuit’s corporate headquarters are in Greenwich, Connecticut.

The collaborative network of scientists at Aptuit sites provide uncommon expertise that allows Aptuit to identify the unexpected, mitigating risks and maximizing promising possibilities, ensuring exceptional results through an open, transparent climate of trust that our clients can count on.

Key Statistics

Ownership: Private

Web Site: Aptuit LLC


Company News
Aptuit LLC Announces Acquisition Of Kuecept Ltd 5/10/2016 10:55:27 AM
Aptuit LLC Announces Acquisition Of Exquiron 4/21/2016 6:42:12 AM
Aptuit LLC And Icagen, Inc. (ICGN) Agree To Strategic Alliance 2/22/2016 11:03:44 AM
Aptuit LLC Announces 16M$ Investment In Capacity And Capability 12/7/2015 12:20:07 PM
Aptuit LLC Announces Expansion Of Integrated CMC Offering (Drug Substance And Drug Product) To Phase 3 And Commercial Scale 7/14/2015 11:03:22 AM
Aptuit LLC Announces Expansion Of Integrated CMC Offering (Drug Substance And Drug Product) To Phase 3 And Commercial Scale 7/13/2015 10:16:35 AM
Aptuit LLC And Axxam SpA Announce Strategic Alliance For Integrated Drug Discovery Services 4/14/2015 11:22:03 AM
Aptuit LLC To Divest Two Non-Core Sites; Facilitates Reinvestment And Accelerated Growth In Core Area Of Integrated Solutions 1/9/2015 8:48:06 AM
Aptuit LLC Adds Hot Melt Extrusion Technology To Its Integrated API And Formulation Development Expertise 12/17/2014 11:31:40 AM
Aptuit LLC Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities 7/16/2014 10:47:34 AM